Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
04/2002
04/25/2002CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis
04/25/2002CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
04/24/2002EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
04/24/2002CN1346355A Novel inhibitors of farnesyl-protein transferase
04/24/2002CN1346351A 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
04/24/2002CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4
04/24/2002CN1346271A Quinazoline derivatives as angiogenesis inhibitors
04/23/2002US6376672 Restenosis; vision defects; cardiovascular disorders; kidney dieases
04/23/2002US6376526 For huans, animals
04/23/2002US6376515 Benzamides and related inhibitors of factor Xa
04/23/2002US6376497 Excellent, wide-spectrum antifungal activities and low toxicity
04/23/2002US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries
04/23/2002US6376429 Controlling weeds
04/23/2002US6376428 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
04/18/2002WO2002030921A1 Herbicidally active pyridine sulfonyl urea derivatives
04/18/2002WO2002030908A1 Inhibitors of protein kinases
04/18/2002WO2002030881A1 Sulfonylguanidine
04/18/2002US20020045762 Process for preparing 1-guanylpyrazole acid adducts
04/18/2002DE10048716A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site
04/18/2002DE10046934A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren A process for the fermentative production of non-proteinogenic L-amino acids
04/18/2002CA2424107A1 Sulfonylguanidines
04/18/2002CA2394084A1 Inhibitors of protein kinases
04/17/2002EP1197486A1 Process for the preparation of 1H-pyrazole-1-carboxamidines
04/17/2002EP1196411A1 Bradykinin b1 receptor antagonists
04/17/2002EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
04/17/2002EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
04/17/2002CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors
04/17/2002CN1344801A Method for production of non-proteinogen L-amino acid by fermentation
04/17/2002CN1082953C Process to prepare oxazolidinones
04/16/2002US6372767 Benzanilides as potassium channel openers
04/16/2002US6372736 Heterocyclic compounds as inhibitors of rotamase enzymes
04/16/2002US6372682 Contacting one or more olefin monomers with a group 8-10 transition metal complex catalyst and optionally a bronsted or lewis acid
04/16/2002CA2218552C Benzimidazole compounds and their use as modulators of the gabaa receptor complex
04/16/2002CA2217601C Benzimidazole compounds and their use as modulators of the gabaa receptor complex
04/11/2002WO2002028839A1 Benzimidazole and indole derivatives as crf receptor modulators
04/11/2002WO2002028810A2 Retinoids for the treatment of emphysema
04/11/2002US20020042414 Antiallergens
04/11/2002US20020042410 Central nervous system disorders therapy
04/11/2002CA2425185A1 Benzimidazole and indole derivatives as crf receptor modulators
04/10/2002EP1195376A1 Azoamidine compounds and their use as polymerization initiators
04/10/2002EP1194410A1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
04/10/2002EP1194227A1 Preparation and use of ionic liquids in microwave-assisted chemical transformations
04/10/2002EP0739338B1 serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide
04/10/2002CN1344254A Quinoline derivatives and quinazoline derivatives
04/10/2002CN1082503C Method of preparing alpha-methoxyiminocarboxylic acid methylamides, and intermediates used in said method
04/09/2002US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors
04/04/2002WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai
04/04/2002WO2001064643A3 Benzamides and related inhibitors of factor xa
04/04/2002US20020040147 Novel catechols as antimicrobial agents
04/04/2002US20020040061 Compounds such as 1-(3-(2-hydroxybenzoylamino)propyl)-2-pyrrolidinone; dosage forms of bioactive agents or drugs
04/04/2002US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example
04/04/2002US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity
04/04/2002US20020039767 Batch processing using nucleophilic compound
04/04/2002DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use
04/04/2002CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai
04/03/2002EP1193259A1 Dihydropyrimidine derivatives
04/03/2002EP1193250A1 Phenyl sulfamate derivatives
04/03/2002EP1192145A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
04/03/2002EP1162201A9 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
04/03/2002EP0865440B1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
04/03/2002CN1082050C Azole cojpounds endowed with antimycotic activity for human and veterinary use
04/02/2002US6365736 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
04/02/2002US6365588 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
04/02/2002US6365301 Delocalized nitrogen, oxygen, sulfur or phoshorous onium cation; bis-fluorosulfonimidide anion or bis-difluorophos-phonylamidide anion
03/2002
03/28/2002WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs
03/28/2002WO2002024687A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
03/28/2002WO2002024686A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
03/28/2002WO2002024685A1 Indole derivatives and their use as antifungal and/or antiparasitic agents
03/28/2002WO2002024682A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
03/28/2002WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY
03/28/2002WO2002024666A2 4-amino-quinazolines
03/28/2002WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs
03/28/2002WO2002024200A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
03/28/2002WO2001083434A3 P-(sulfonyl)-aryl and heteroaryls amines
03/28/2002US20020038059 Purification of alkenyl compounds
03/28/2002US20020038030 For therapy of inflammatory conditions including migraine, rheumatoid arthritis, asthma, and inflammatory bowel disease as well as mediation of the emetic reflex and the modulation of central nervous system (CNS) disorders such as Parkinson's
03/28/2002US20020037907 Substituted 2- (S) -hydroxy-3- (piperidin-4-yl-methylamino) -propyl ethers and substituted 2-aryl-2- (R) - hydroxy-1- (piperidin-4-yl-methyl) -ethylamine beta-3 adrenergic receptor agonists
03/28/2002US20020037896 Bicyclic compounds
03/28/2002US20020037888 4-imidazol-1-ylmethyl-2-(2-(2-oxo-piperidin-1-yl)-phenoxy) -benzonitrile for example; farnesyl-protein transferase inhibitors; treating cancer, benign proliferative disorder, hepatitis virus, restenosis, and polycystic kidney disease
03/28/2002US20020037324 Aqueous solubility pharmaceutical formulations
03/28/2002CA2423156A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
03/28/2002CA2423151A1 Indole derivatives and their use as antifungal and/or antiparasitic agents
03/28/2002CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity
03/28/2002CA2422560A1 4-amino-quinazolines
03/27/2002EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren
03/27/2002EP1189879A1 INHIBITORS OF FACTOR Xa
03/27/2002EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
03/27/2002CN1342145A Fused-ring compounds and use thereof as drugs
03/27/2002CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists
03/26/2002US6362373 Chiral amino alcohols and process for preparation of same
03/26/2002US6362334 Phthalamide compounds
03/26/2002US6362206 Azole compounds, their production and use
03/26/2002US6362189 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
03/26/2002US6362188 Farnesyl protein transferase inhibitors
03/26/2002US6362134 Controlling plant growth
03/26/2002US6361920 Photographic material containing a novel hydrazide type
03/26/2002CA2032498C Novel 8-substituted-2-aminotetralines
03/21/2002WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 163